Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma

MLA

Franca De Paola, et al. Adjuvant Immunotherapy with Tumor Infiltrating Lymphocytes and Interleukin-2 in Patients with Resected Stage III and IV Melanoma. Jan. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1ed96a0c626abcd4d9da4931bda491e&authtype=sso&custid=ns315887.

APA

Franca De Paola, Dino Amadori, Angela Riccobon, Massimiliano Petrini, Alessandra Ravaioli, Ruggero Ridolfi, Laura Ridolfi, E. Flamini, Giorgio Maria Verdecchia, Giusto Trevisan, & Monica Stefanelli. (2003). Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.

Chicago

Franca De Paola, Dino Amadori, Angela Riccobon, Massimiliano Petrini, Alessandra Ravaioli, Ruggero Ridolfi, Laura Ridolfi, et al. 2003. “Adjuvant Immunotherapy with Tumor Infiltrating Lymphocytes and Interleukin-2 in Patients with Resected Stage III and IV Melanoma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1ed96a0c626abcd4d9da4931bda491e&authtype=sso&custid=ns315887.